These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35735153)

  • 1. [Tobacco cessation treatment for people with schizophrenia].
    Papachristou C; Humair JP
    Rev Med Suisse; 2022 Jun; 18(787):1275-1278. PubMed ID: 35735153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
    Bailey SR; Crew EE; Riske EC; Ammerman S; Robinson TN; Killen JD
    Paediatr Drugs; 2012 Apr; 14(2):91-108. PubMed ID: 22248234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study.
    Thomas KH; Martin RM; Davies NM; Metcalfe C; Windmeijer F; Gunnell D
    BMJ; 2013 Oct; 347():f5704. PubMed ID: 24124105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Stopping and reducing smoking in patients with schizophrenia].
    Underner M; Perriot J; Brousse G; de Chazeron I; Schmitt A; Peiffer G; Harika-Germaneau G; Jaafari N
    Encephale; 2019 Sep; 45(4):345-356. PubMed ID: 31153585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for smoking cessation in schizophrenia: a systematic review.
    Kozak K; George TP
    Expert Opin Pharmacother; 2020 Apr; 21(5):581-590. PubMed ID: 32011186
    [No Abstract]   [Full Text] [Related]  

  • 7. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varenicline: a first-line treatment option for smoking cessation.
    Garrison GD; Dugan SE
    Clin Ther; 2009 Mar; 31(3):463-91. PubMed ID: 19393839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.
    Keating GM; Lyseng-Williamson KA
    Pharmacoeconomics; 2010; 28(3):231-54. PubMed ID: 20108995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential tobacco dependence medicines in 137 countries.
    Benipal S; Budhram DR; Bilimoria K; Woods H; Wang R; Persaud N
    Addiction; 2021 Jun; 116(6):1606-1609. PubMed ID: 33022824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm.
    Rose JE; Behm FM
    Am J Psychiatry; 2014 Nov; 171(11):1199-205. PubMed ID: 24934962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.
    Hays JT; Ebbert JO
    Drugs; 2010 Dec; 70(18):2357-72. PubMed ID: 21142259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preliminary benefit-risk assessment of varenicline in smoking cessation.
    Cahill K; Stead L; Lancaster T
    Drug Saf; 2009; 32(2):119-35. PubMed ID: 19236119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological strategies for smoking cessation in patients with chronic obstructive pulmonary disease: a pragmatic review.
    Antoniu SA; Buculei I; Mihaltan F; Crisan Dabija R; Trofor AC
    Expert Opin Pharmacother; 2021 May; 22(7):835-847. PubMed ID: 33372557
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatments for smoking cessation.
    Cahill K; Stevens S; Lancaster T
    JAMA; 2014 Jan; 311(2):193-4. PubMed ID: 24399558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of varenicline for smoking cessation.
    Hays JT; Ebbert JO; Sood A
    Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varenicline versus bupropion XL for smoking cessation in older adolescents: a randomized, double-blind pilot trial.
    Gray KM; Carpenter MJ; Lewis AL; Klintworth EM; Upadhyaya HP
    Nicotine Tob Res; 2012 Feb; 14(2):234-9. PubMed ID: 21778151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.